Inari Medical Valuation
| NARI Stock | USD 79.69 0.01 0.01% |
At this time, the firm appears to be overvalued. Inari Medical retains a regular Real Value of $72.99 per share. The prevalent price of the firm is $79.69. Our model calculates the value of Inari Medical from evaluating the firm fundamentals such as Return On Equity of -0.18, current valuation of 4.59 B, and Return On Asset of -0.0321 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Inari Medical's valuation include:
Price Book 10.7345 | Enterprise Value | Enterprise Value Ebitda 1.6 K | Price Sales 8.1235 | Forward PE 526.3158 |
Overvalued
Today
Please note that Inari Medical's price fluctuation is very steady at this time. Calculation of the real value of Inari Medical is based on 3 months time horizon. Increasing Inari Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Inari Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Inari Stock. However, Inari Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 79.69 | Real 72.99 | Target 74.12 | Hype 79.64 | Naive 72.26 |
The intrinsic value of Inari Medical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Inari Medical's stock price.
Estimating the potential upside or downside of Inari Medical helps investors to forecast how Inari stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Inari Medical more accurately as focusing exclusively on Inari Medical's fundamentals will not take into account other important factors: When choosing an evaluation method for Inari Medical, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Inari Medical Cash |
|
Inari Valuation Trend
Inari Medical's real value analysis enables investors to forecast the earnings more efficiently. Using both Inari Medical's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Inari Medical Total Value Analysis
Inari Medical is now projected to have valuation of 4.59 B with market capitalization of 4.67 B, debt of 32.05 M, and cash on hands of 330.5 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Inari Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.59 B | 4.67 B | 32.05 M | 330.5 M |
Inari Medical Investor Information
About 97.0% of the company shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 275.35. Inari Medical recorded a loss per share of 1.35. The entity had not issued any dividends in recent years. Inari Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Inari Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Inari Medical has an asset utilization ratio of 73.21 percent. This signifies that the Company is making $0.73 for each dollar of assets. An increasing asset utilization means that Inari Medical is more efficient with each dollar of assets it utilizes for everyday operations.Inari Medical Ownership Allocation
Inari Medical has a total of 58.56 Million outstanding shares. The majority of Inari Medical outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Inari Medical to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Inari Medical. Please pay attention to any change in the institutional holdings of Inari Medical as this could imply that something significant has changed or is about to change at the company. Also note that almost two million nine hundred four thousand seven hundred fifty-five invesors are currently shorting Inari Medical expressing very little confidence in its future performance.Inari Medical Profitability Analysis
The company reported the previous year's revenue of 493.63 M. Net Loss for the year was (1.64 M) with profit before overhead, payroll, taxes, and interest of 498.76 M.About Inari Medical Valuation
An absolute valuation paradigm, as applied to Inari Stock, attempts to find the value of Inari Medical based on its fundamental and basic technical indicators. By analyzing Inari Medical's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Inari Medical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Inari Medical. We calculate exposure to Inari Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Inari Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 499.7 M | 524.7 M | |
| Pretax Profit Margin | 0.01 | 0.01 | |
| Operating Profit Margin | (0.03) | (0.03) | |
| Gross Profit Margin | 0.79 | 0.70 |
Inari Medical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 56.8 M | |
| Quarterly Earnings Growth Y O Y | -0.839 | |
| Forward Price Earnings | 526.3158 |
Inari Medical Current Valuation Indicators
Valuation refers to the process of determining the present value of Inari Medical and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Inari we look at many different elements of the entity such as Inari's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Inari Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Inari Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Inari Medical's worth.Complementary Tools for Inari Stock analysis
When running Inari Medical's price analysis, check to measure Inari Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inari Medical is operating at the current time. Most of Inari Medical's value examination focuses on studying past and present price action to predict the probability of Inari Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inari Medical's price. Additionally, you may evaluate how the addition of Inari Medical to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |